To Verify Tissue Heating and Temperature Stability and Safety Throughout RF Treatment Duration Applied on the Face

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lumenis
LumenisAustralia - Chatswood
1 program
NuEra Tight RF systemN/A1 trial
Active Trials
NCT05957029Completed46Est. Jul 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
LumenisNuEra Tight RF system

Clinical Trials (1)

Total enrollment: 46 patients across 1 trials

NCT05957029LumenisNuEra Tight RF system

Evaluation of Thermal Outcome and Safety of Nuera Tight RF System

Start: Jun 2023Est. completion: Jul 202346 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space